Table 5.
Study 2 (Ethiopia): sero-positivity of the four rk28 RDTs used in the study tested with healthy non-endemic controls and different patient serum panel
| Serum panels | DAT | DPP | CTK | EMT | InBios* |
|---|---|---|---|---|---|
| Number positive/number tested (% positive) | |||||
| VL | 95/99 (95.9) | 99/100 (99.0) | 98/100 (98.0) | 98/100 (98.0) | 96/100 (96.0) |
| Healthy, non-endemic controls | 0/49 (0.0) | 3/50 (6.0) | 0/50 (0.0) | 1/50 (2.0) | 1/50 (2.0) |
| Malaria | 0/42 (0.0) | 13/47 (27.6) | 4/47 (8.5) | 20/47 (42.5) | 23/47 (48.9) |
| Pulmonary TB | 3/19 (15.7) | 3/22 (13.6) | 3/22 (13.6) | 2/22 (9.1) | 2/22 (9.1) |
| Intestinal schistosomiasis | 0/23 (0.0) | 5/25 (20.0) | 1/25 (4.0) | 3/25 (12.0) | 3/25 (12.0) |
*
RDTs = rapid diagnostic tests; DAT = direct agglutination test; DPP = dual path platform; EMT = EASE-Medtrend test; VL = visceral leishmaniasis; TB = tuberculosis.